Loading chat...
MI HB5407
Bill
Status
10/22/2014
Primary Sponsor
Anthony Forlini
Click for details
AI Summary
-
Defines "opioid antagonist" as naloxone hydrochloride or other FDA-approved drugs for treating drug overdose, and "opioid-related overdose" as conditions including extreme illness, decreased consciousness, respiratory depression, coma, or death resulting from opioid consumption.
-
Allows prescribers and pharmacists to dispense opioid antagonists to patients at risk of overdose, family members, friends, or other individuals in position to assist, without requiring a patient-prescriber relationship for these recipients.
-
Permits non-individual entities (organizations) to possess and dispense opioid antagonists when acting under prescriber direction, properly storing the drug, and dispensing without charge or compensation.
-
Provides liability protection for prescribers, dispensing prescribers, and pharmacists who properly dispense opioid antagonists in good faith and with reasonable care.
-
Requires the Department of Community Health to publish an annual report by February 1 documenting opioid-related overdose fatalities, trends, patterns, risk factors, and effective interventions from the preceding calendar year.
Legislative Description
Health; pharmaceuticals; opioid antagonist including naloxone hydrochloride; allow prescribers to prescribe and pharmacists to dispense under certain circumstances to friends or family of individuals who may suffer overdose, and require department to publish a report. Amends secs. 1106, 17745, 17751, 17754 & 17757 of 1978 PA 368 (MCL 333.1106 et seq.) & adds secs. 7421 & 17744b.
State agencies (existing), community health
Last Action
Assigned Pa 311'14 With Immediate Effect
10/22/2014